Antineoplastic activity of acetone semicarbazone (ASC) against Ehrlich ascites carcinoma (EAC) bearing mice

Journal of the National Science Foundation of Sri Lanka

Volumn 38, Issue 4, 2010, Pages 225-231

  Khanam, J A ^a   Islam, M F ^a   Jesmin, M ^a   Ali, M M ^a  

^a UNIVERSITY OF RAJSHAHI   (Bangladesh)

Author keywords

Acetone semicarbazone; Antineoplastic activity; EAC cells; Haematology

Indexed keywords

EID: 79953863845     PISSN: 13914588     EISSN: None     Source Type: Journal    
DOI: 10.4038/jnsfsr.v38i4.2649     Document Type: Article

References (34)

1. Abdullaev F.I., Luna R.R., Roitenburd B.V. & Espinosa A.J. (2000). Pattern of childhood cancer mortality in Mexico. Archives of Medical Research 31(5):526-531.
2. Pandeya S.N., Sriram D., Nath G. & Declereq E. (1999). Synthesis, antibacterial, antifungal and anti-HIV activities of schiff and mannich bases derived from isatin derivatives and N-[4-(4′-chlorophenyl)thiazol-2-yl] thiosemicarbazide. European Journal of Pharmaceutical Sciences 9(1): 25-31.
3. Jesmin M., Ali M.M., Salahuddin M.S., Habib M.R. & Khanam J. A (2008). Antimicrobial activity of some schiff bases derived from benzoin, salicylaldehyde, aminophenol and 2, 4-dinitro phenyl hydrazine. Mycobiology 36(1): 70-73.
4. Boon R. (1997). Antiviral treatment: from concept to reality. Antiviral Chemistry and Chemotherapy 8: 5-10.
5. Shipman C., Smith S.H., Drach J.C. & Klayman D. L. (1986). Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model. Antiviral Research 6(4):97-222.
6. Islip J., Closier M.D. & Neville M.C. (1974). Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. Journal of Medicinal Chemistry 17(2): 207-209.
7. Islam M.R., Mirza A.H., Huda Q.M.W. & Khan B.R. (1989). The synthesis of some antitubercular agents, aldehyde thiosemicarbazones and 1,2,3 thiodiazotine derivatives. Journal of the Bangladesh Chemical Society 2:89-95.
8. Dobek A.S., Klayman D.L., Dickson E.T., Scovill J.P. & Oster C.N. (1983). Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-and 3-acetylisoquinoline and related compounds as inhibitors of clinically significant bacteria in vitro. Arzneimittel-Forschung-Drug Research 33(11):1583-1591.
9. Klayman D.L., Scovill J.P., Bartosevich J.F. & Mason C. J. (1979). 2-Acetylpyridine thiosemicarbazones. 2. N4, N4-disubstituted derivatives as potential antimalarial agents. Journal of Medicinal Chemistry 22(11):1367-1373.
10. Molla B.S., Rao B.S., Shridhara K. & Akberali P. M. (2000). Studies on arylfuran derivatives, part IX. synthesis, characterization and biological studies on some mannich bases carrying 2,4-dichlorophenyl furfural moeity. Farmacology 55:338-344.
11. Klayman D.L., Scovill J.P., Mason C.J., Bartosevich J.F., Bruce J. & Lin A.J. (1983). 2-Acetylpyridinethiosemicarbazones,6.2-Acetylpyridine and 2-butyrylpyridine thiosemicarbazones as antileukemic agents. Arzneimittel-Forschung-Drug Research 33(7):909-912.
12. Ren S., Wang R., Komatsu K., Bonaz-Krause P., Zyrianov Y., McKenna C.E., Csipke C., Tokes Z.A. & Lien E.J. (2002). Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. Journal of Medicinal Chemistry 45(2):410-419.
13. T'ang A., Lien E.J. & Lai M.M. (1985). Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agents. Journal of Medicinal Chemistry 28(8):1103-1106.
14. Afrasiabi Z., Sinn E., Lin W., Ma Y., Campana C. & Padhya S. (2005). Nickel (II) complexes of naphthaquinone thiosemicarbazone and semicarbazone: synthesis, structure, spectroscopy, and biological activity. Journal of Inorganic Biochemistry 99(7):1526-1531.
15. Hall I.H., Wong O.T. & Chapman J. M. (1995). Cytotoxicity of imides-N-alkyl semicarbazones, thiosemicarbazones, acetylhydrazones and related derivatives. Anticancer Drugs 6(1):147-153.
16. Liu M.C., Lin T.S. & Sartorelli A.C. (1992). Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone. Journal of Medicinal Chemistry 35(20):3672-3677.
17. Richardson D. R, Sharpe P.C., Lovejoy D.B., Senaratne D., Kalinowski D.S., Islam M. & Bernhardt P.V. (2006). Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. Journal of Medicinal Chemistry 49(22):6510-6521.
18. nd edition. Part:2 Qualitative Organic Analysis p. 118. Longman Publication, London.
19. th edition p. 117, Edward Arnold publishers, London.
20. Litchfield J.T. & Wilcoxon F. (1949). A simplified method of evaluating dose-effect experiments. Journal of Pharmacology and Experimental Therapeutics 96: 99-113.
21. Sur P. & Ganguly D.K. (1994). Tea plant root extract (TRE) as an antineoplastic agent. Planta Medica 60:106-109.
22. Abbot B.J. (1976). Bioassay of plant extracts for anticancer activity. Cancer Treatment Reports 60:1007-1017.
23. Rusia U. & Sood S.K. (1988). Medical Laboratory Technology: A Procedure Manual for Routine Diagnostic Tests. Vol. 1: Chapter 10:228. Ed. K.L. Mukherjee, Tata McGraw Hill Comp. Ltd., New Delhi.
24. Mukherjee K.L. (1988). Medical Laboratory Technology. volume 1: pp. 215-280. Tata McGraw Hill Publishers. Company Ltd: New Delhi: pp. 215-280.
25. Hudson L. & Hay F.C. (1989). Practical Immunology p.26. Blackwell Science Publisher, Oxford, London.
26. Meyer B.N., Ferringni N.R., Putnam J.E., Jacobsen L.B., Nichols D.E. & Mclaughlin J.L.A. (1982). Convenient general bioassay for active plant constituents. Planta Medica 45:34-39.
27. Finney D.J. (1971). Probit Analysis. p. 333 Cambridge University Press, London.
28. Clarkson B.D. & Burchenal J.H. (1965). Preliminary screening of antineoplastic drugs. Progress in Clinical Cancer: 1:625-629.
29. Price V. E. & Greenfield R.E. (1958), Anemia in cancer. Advances in Cancer Research 5:199-200.
30. Hoaglad H.C. (1982). Hematological complication in cancer chemotherapy. Semin Oncology 9:95-102.
31. Fenninger L.D. & Mider G.B. (1954). Energy and nitrogen metabolism in cancer. Advances in Cancer Research 2: 2229-2253.
32. rd edition, Volume 2, pp. 2:602-653. John Wiley & Sons, London.
33. Fernandes D.J. & Klubes P. (1979). A biochemical and pharmacological study of therapeutic system with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia. Cancer Research 39: 1396-1404.
34. Lee N.N., Cadman E.C., Michael I.N., Michael C., Joseph R., Bertino Farber L.R. & Prosnitz L.R. (1982). Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. Cancer Treatment Report 66 (6):1279-1284.